CNSY - Cerenome, Inc. logo

Cerenome, Inc.

CNSY
โš•๏ธ Healthcare NASDAQ Listed 2000 $ USD
$1,000 invested 20 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-16.54%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-19.37%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-94.70%
Net Trend40%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trend50%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-18.33%
Net Trend50%
Net Income Consistency
Rev Growth-63.07%
Rev Trend38%
Revenue Consistency
20 Years
Score2.7
Net Growth1.70%
Net Trend50%
Net Income Consistency
Rev Growth-30.01%
Rev Trend44%
Revenue Consistency
All Time
Score
Net Growth-201.77%
Net Trend48%
Net Income Consistency
Rev Growth-32.76%
Rev Trend43%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Cerenome, Inc. has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. CNSY does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 1.64โ€”
1 Year2025-10-23
$ 15.75-89.59%
5 Years2021-10-22
$ 618.75-99.73%
10 Years2016-10-21
$ 345K-100.00%
20 Years2006-10-23
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 4M-$ 26M$ 8M
2025$ 5M-$ 22M$ 8M
2024$ 5M-$ 12M$ 3M
2023$ 4M-$ 13M$ 8M
2022$ 224K-$ 20M$ 18M
2021-$ 13M$ 18M
2020$ 303K-$ 8M$ 8M
2019$ 6M-$ 10M$ 17M
2018$ 2M-$ 12M$ 5M
2017$ 6M-$ 22M$ 9M
2016$ 11M-$ 22M$ 12M
2014$ 7M-$ 37M$ 14M
2013$ 12M-$ 26M$ 15M
2012$ 14M-$ 32M$ 25M
2011$ 9M-$ 32M$ 36M
2010$ 10M-$ 27M$ 52M
2009$ 14M-$ 23M$ 12M
2008$ 6M-$ 30M$ 12M
2007$ 6M-$ 28M$ 11M
2006$ 7M-$ 25M$ 12M
2005$ 6M-$ 26M$ 15M
2004$ 6M-$ 2M$ 13M
2003$ 14M-$ 9M$ 14M
2002$ 9M-$ 13M$ 24M
2001$ 5M-$ 11M$ 33M
IPO2000$ 6M-$ 8M$ 44M
CNSY - Cerenome, Inc. logo

Cerenome, Inc. fundamental performance

Between 2014 and 2025, revenue declined from $ 7M to $ 5M and net income went from -$ 37M to -$ 22M. Revenue increased in 38% of the years measured; net income in 50%.

Between 2004 and 2025, revenue declined from $ 6M to $ 5M and net income went from -$ 2M to -$ 22M. Revenue increased in 44% of the years measured; net income in 50%.

Cerenome, Inc. currently holds a 20-year HDB Score of 2.7 out of 10. How the HDB Score is calculated.

Membership

Explore CNSY with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies